Supplemental Data - Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis

Published: 3 February 2025| Version 1 | DOI: 10.17632/8b7cy856x2.1
Contributors:
Yuhsin Huang, Han Zhu, Yin Sun

Description

Flow cytometry data for "Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis" - CXCR3 Blockade transwell assay - CD49d expression after CXCL9/10 Stimulation assay - Cardiomyocytes apoptosis assay - anti-PD1/CTLA-4 Immunotherapy Model - 10-02-23 in Vitro rmCXCL9 rmCXCL10 - 9-21-23 in Vitro CXCL9 CXCL10 Blockade Automated Quantification Script imagej-script.txt

Files

Institutions

Stanford University

Categories

Immunology, Myocarditis, Chemokine Response, Cardiology, Immune Checkpoint Inhibitor

Licence